203 related articles for article (PubMed ID: 9439668)
21. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p.
Bale SJ; Dracopoli NC; Tucker MA; Clark WH; Fraser MC; Stanger BZ; Green P; Donis-Keller H; Housman DE; Greene MH
N Engl J Med; 1989 May; 320(21):1367-72. PubMed ID: 2716782
[TBL] [Abstract][Full Text] [Related]
22. The genetics of hereditary melanoma and nevi. 1998 update.
Greene MH
Cancer; 1999 Dec; 86(11 Suppl):2464-77. PubMed ID: 10630172
[TBL] [Abstract][Full Text] [Related]
23. Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.
Yang XR; Pfeiffer RM; Wheeler W; Yeager M; Chanock S; Tucker MA; Goldstein AM
Int J Cancer; 2009 Dec; 125(12):2912-7. PubMed ID: 19626699
[TBL] [Abstract][Full Text] [Related]
24. Molecular genetics of familial cutaneous melanoma.
Haluska FG; Hodi FS
J Clin Oncol; 1998 Feb; 16(2):670-82. PubMed ID: 9469357
[TBL] [Abstract][Full Text] [Related]
25. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.
Borg A; Sandberg T; Nilsson K; Johannsson O; Klinker M; Måsbäck A; Westerdahl J; Olsson H; Ingvar C
J Natl Cancer Inst; 2000 Aug; 92(15):1260-6. PubMed ID: 10922411
[TBL] [Abstract][Full Text] [Related]
26. Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study.
Nielsen K; Ingvar C; Måsbäck A; Westerdahl J; Borg A; Sandberg T; Jonsson N; Nagel J; Olsson H
Br J Dermatol; 2004 Mar; 150(3):531-6. PubMed ID: 15030338
[TBL] [Abstract][Full Text] [Related]
27. Hereditary malignant melanoma is not linked to the HLA complex on chromosome 6.
Bale SJ; Greene MH; Murray C; Goldin LR; Johnson AH; Mann D
Int J Cancer; 1985 Oct; 36(4):439-43. PubMed ID: 4044054
[TBL] [Abstract][Full Text] [Related]
28. Reply to: "The absence of multiple atypical nevi in germline CDKN2A mutations".
Soura E; Stratigos AJ; Tsao H
J Am Acad Dermatol; 2016 Oct; 75(4):e159. PubMed ID: 27646764
[No Abstract] [Full Text] [Related]
29. Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32.
Jönsson G; Bendahl PO; Sandberg T; Kurbasic A; Staaf J; Sunde L; Crüger DG; Ingvar C; Olsson H; Borg A
J Natl Cancer Inst; 2005 Sep; 97(18):1377-82. PubMed ID: 16174859
[TBL] [Abstract][Full Text] [Related]
30. Genetics of cutaneous melanoma and nevi.
Greene MH
Mayo Clin Proc; 1997 May; 72(5):467-74. PubMed ID: 9146691
[TBL] [Abstract][Full Text] [Related]
31. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).
Vasen HF; Gruis NA; Frants RR; van Der Velden PA; Hille ET; Bergman W
Int J Cancer; 2000 Sep; 87(6):809-11. PubMed ID: 10956390
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of Germline BAP1, CDKN2A, and CDK4 Mutations in an Australian Population-Based Sample of Cutaneous Melanoma Cases.
Aoude LG; Gartside M; Johansson P; Palmer JM; Symmons J; Martin NG; Montgomery GW; Hayward NK
Twin Res Hum Genet; 2015 Apr; 18(2):126-33. PubMed ID: 25787093
[TBL] [Abstract][Full Text] [Related]
33. Retention of the CDKN2A locus and low frequency of point mutations in primary and metastatic cutaneous malignant melanoma.
Ruiz A; Puig S; Lynch M; Castel T; Estivill X
Int J Cancer; 1998 May; 76(3):312-6. PubMed ID: 9579564
[TBL] [Abstract][Full Text] [Related]
34. Risks of Melanoma and Other Cancers in Melanoma-Prone Families over 4 Decades.
Tucker MA; Elder DE; Curry M; Fraser MC; Pichler V; Zametkin D; Yang XR; Goldstein AM
J Invest Dermatol; 2018 Jul; 138(7):1620-1626. PubMed ID: 29408205
[TBL] [Abstract][Full Text] [Related]
35. Improvement of Genetic Testing for Cutaneous Melanoma in Countries With Low to Moderate Incidence: The Rule of 2 vs the Rule of 3.
Delaunay J; Martin L; Bressac-de Paillerets B; Duru G; Ingster O; Thomas L
JAMA Dermatol; 2017 Nov; 153(11):1122-1129. PubMed ID: 28903138
[TBL] [Abstract][Full Text] [Related]
36. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.
Tucker MA; Fraser MC; Goldstein AM; Struewing JP; King MA; Crawford JT; Chiazze EA; Zametkin DP; Fontaine LS; Clark WH
Cancer; 2002 Jun; 94(12):3192-209. PubMed ID: 12115352
[TBL] [Abstract][Full Text] [Related]
37. Influence of genes, nevi, and sun sensitivity on melanoma risk in a family sample unselected by family history and in melanoma-prone families.
Chaudru V; Chompret A; Bressac-de Paillerets B; Spatz A; Avril MF; Demenais F
J Natl Cancer Inst; 2004 May; 96(10):785-95. PubMed ID: 15150307
[TBL] [Abstract][Full Text] [Related]
38. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.
Hashemi J; Platz A; Ueno T; Stierner U; Ringborg U; Hansson J
Cancer Res; 2000 Dec; 60(24):6864-7. PubMed ID: 11156381
[TBL] [Abstract][Full Text] [Related]
39. A locus linked to p16 modifies melanoma risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families.
van der Velden PA; Sandkuijl LA; Bergman W; Hille ET; Frants RR; Gruis NA
Genome Res; 1999 Jun; 9(6):575-80. PubMed ID: 10400925
[TBL] [Abstract][Full Text] [Related]
40. The inheritance of cutaneous malignant melanoma (CMM) and dysplastic nevus syndrome (DNS).
Pascoe L
Am J Hum Genet; 1987 May; 40(5):464-5. PubMed ID: 3578283
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
